Mi az ára Proteome Sciences plc (PRM)

Proteome Sciences plc (PRM) ára $0.02263255

Mi a Proteome Sciences plc (PRM piaci tőkésítése)

Proteome Sciences plc piaci tőkésítése (PRM) $65.39K

Proteome Sciences plc (PRM) Ár és Piaci Kapitalizáció

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant that provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator which analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids. It also offers top 14 and top 65 super depletion of proteins from serum and plasma; selective reaction monitoring (SRM) and parallel reaction monitoring (PRM) based biomarker assay development; SRM assay, a targeted mass spectrometry assay format for the routine measurement of biomarkers; and TMT SRM, a targeted assay format that enables the rapid validation of biomarker candidates. The company serves its products to pharmaceutical and biotechnology companies, as well as to academic research institutes. The company was incorporated in 1993 and is based in Cobham, the United Kingdom.

A PRM ára	B aktíva	A B piaci tőkésítése	Eredmények
$1,891,920 $65.39K	NVDA	$5.466T	+8,359,289,898.35%
$1,550,208 $65.39K	AAPL	$4.479T	+6,849,462,877.13%
$1,445,271 $65.39K	GOOG	$4.176T	+6,385,806,622.02%
$1,277,021 $65.39K	MSFT	$3.690T	+5,642,406,855.49%
$997,549 $65.39K	AMZN	$2.882T	+4,407,586,085.59%

A PRM ára

B aktíva

A B piaci tőkésítése

Eredmények

$1,891,920 $65.39K